— Veru Inc. (NASDAQ: VERU) reported Q1 2020 loss of $0.05 per share, vs. $0.02 expected. — Revenues grew 66% to $10.6 million, vs. $8.7 million expected. — FC2 US prescription net revenues increased 148% to $6.1 million. — Gross profit increased 57% to $7.3 million. — VERU shares were up 3.7% in premarket hours […]
— Veru Inc. (NASDAQ: VERU) reported Q1 2020 loss of $0.05 per share, vs. $0.02 expected. — Revenues grew 66% to $10.6 million, vs. $8.7 million expected. — FC2 US prescription net revenues increased 148% to $6.1 million. — Gross profit increased 57% to $7.3 million. — VERU shares were up 3.7% in premarket hours […]
— Veru Inc. (NASDAQ: VERU) reported Q1 2020 loss of $0.05 per share, vs. $0.02 expected.
— Revenues grew 66% to $10.6 million, vs. $8.7 million
expected.
— FC2 US prescription net revenues increased 148% to $6.1
million.
— Gross profit increased 57% to $7.3 million.
— VERU shares were up 3.7% in premarket hours on Wednesday.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
